Biopreservation Market Size & Forecast Report, 2012 - 2022

Industry Insights

The global Biopreservation Market size is likely to reach USD 8.93 billion by 2022 which is projected to grow at a CAGR of 17.3% during the forecast period. Rapid growth can be attributed to the rise in healthcare expenditure which is expected to boost the market in the forecast period.

Moreover, increasing R&D activities by various companies as well as research organizations funded by government initiatives in the form of grants, contracts, and various other funding mechanisms have led to the development of novel and innovative bio-preservation services, leading to augment revenue growth.

The growing use of bio-preservation is also supported by the rising participation of government or non-government bodies for the development of this field. For example, due to the support of the institutional and government repositories, the storage of bio-specimen has evolved to the next level of advanced information from basics of patient’s phenotype, extending to genetics as well as “omics” such as proteomic information.

Product Insights

The key segments included laboratory information management systems (LIMS), media, and equipment. In 2014, the equipment segment dominated the market which includes liquid nitrogen, consumables, refrigerators, and freezers, having a revenue share of more than 80%. The larger share can be attributed to the high demands about bio-banks and the extensive use and importance of the aforementioned products in bio-preservation. The media segment which includes home-brewed and pre-formulated media is projected to witness healthy growth as a consequence of the increased demands of tissues, cells, and other materials in biobanking and advanced products in regenerative medicines. Furthermore, the high share and preference of home-brewed media in terms of bio-storage can be attributed to its cost-efficiency and effectiveness in comparison to pre-formulated media.

Application Insights

The major application analyzed in the study comprised drug discovery, bio-banking, and regenerative medicines. Moreover, the further segmentation of bio-banking includes veterinary IVF, human sperm, and human eggs. The Bio-banking segment held the largest share of 72.5% in 2014. Rising awareness related to the preservation of stem cells, the use of assisted technology for reproduction in animals, and the increasing number of sperm and egg banks are anticipated to drive the growth. Additionally, the expected rise in the revenue share of the segment can be attributed to the advent of new techniques used for the preservation of cells for a longer period. Regenerative medicine is considered to be the fastest-growing segment owing to the high demand for efficient and specialized techniques for bio-storage. Moreover, a huge amount of investments by non-government or government organizations in the field of regenerative cell therapy research is projected to boost the growth of the overall market.

Cell providers Insights

The segment of cell providers can be analyzed on basis of tumor cells, hESC, iPSC, MSC, CD19+, and CD34+. The largest market share was held by tumor cells in terms of volume in 2014 as a consequence of their wide array of applications in treatment, diagnosis, and R&D of the most prevalent forms of cancer. However, the fastest-growing segment is predicted to be the iPSC segment throughout the forecast period because of their promising application in regenerative medicines owing to their high propagating capacity.

Regional Insights

The key market in 2014 was North American having a revenue share of more than 45% owing to the innovative drug developments and therapies for biomedical research. Also, the continuous rise in the population base with chronic and acute disorders requiring treatment and diagnosis in the region is further driving revenue generation. Asia Pacific region is expected to show a considerable growth rate over the forecast period owing to the rise in population base suffering from life-threatening disorders. Moreover, increasing investments by the government in R&D is leading to an urgent need for bio-storage, therefore providing a boost to the regional market.

Market Share Insights

The key players holding a significant share of the biopreservation market include Qiagen, Thermo Fisher Scientific Inc, Panasonic Biomedical, Atlanta Biologicals, LabVantage Solutions Inc., Chart MVE Biomedical, BioLife Solutions Inc., Biomatrica, and BioCision. The strategic initiatives by the company including acquisitions, mergers, and new product launches are done to maintain and gain a competitive edge. For instance, ATCC and BioCision in May 2013 agreed to distribute and develop a line of CoolProducts having a wide array of applications in wielding procedures and biomaterials storage.

Market Segment:

Biopreservation Product Outlook (Revenue, USD Billion, 2012 - 2022)
    • Equipment
        • Freezers
        • Refrigerators
        • Consumables
            • Vials
            • Straws
            • Microtiter Plates
            • Bags
        • Liquid Nitrogen
    • Media
        • Pre-formulated
        • Home-brew
    • Laboratory Information Management System (LIMS)

Biopreservation Application Outlook (Revenue, USD Billion, 2012 - 2022)
    • Regenerative Medicine
        • Cell therapy
        • Gene therapy
        • Others
    • Bio-banking
        • Human eggs
        • Human sperms
        • Veterinary IVF
    • Drug Discovery

Biopreservation Cell Providers Outlook (Volume, Number of Units, 2012 - 2022)
    • CD34+
    • CD19+
    • MSC
    • iPSC
    • hESC
    • Tumor Cells
    • Others

Biopreservation Market Regional Outlook (Revenue, USD Billion, 2012 - 2022)
    • North America
        • U.S.
        • Canada
    • Europe
        • UK
        • Germany
    • the Asia Pacific
        • Japan
        • China
    • Latin America
        • Brazil
        • Mexico
    • MEA
        • South Africa